Controlled Drugs and Substances Act

CBSA firearms investigation in Greater Toronto Area leads to criminal charges

Retrieved on: 
Wednesday, October 11, 2023
Weapon, Firearm, Cocaine, Intelligence, National Building Code of Canada, Criminal code, CBSA, Customs Act 1967, Safety, Arrest, Controlled Drug in the United Kingdom, Canada Border Services Agency, Law enforcement, Controlled Drugs and Substances Act, Narcotic, Seizure, Controlled Substances Act, Drug, Gunsmith

The CBSA announced today that an arrest has been made for firearms, weapons and smuggling offences as part of an investigation by the CBSA Ontario Firearms Smuggling Enforcement Team (OFSET).

Key Points: 
  • The CBSA announced today that an arrest has been made for firearms, weapons and smuggling offences as part of an investigation by the CBSA Ontario Firearms Smuggling Enforcement Team (OFSET).
  • The OFSET is a group of CBSA criminal investigators, intelligence analysts and intelligence officers dedicated to stopping firearms smuggling at ports of entry throughout the province.
  • "The CBSA Ontario Firearms Smuggling Enforcement Team is working hard to keep our communities safe.
  • If you have information about suspicious cross-border activity, please contact the CBSA Border Watch toll-free line at 1-888-502-9060.

Statement from the Minister of Mental Health and Addictions and Associate Minister of Health

Retrieved on: 
Thursday, September 14, 2023
Government, Law enforcement, Prohibition of drugs, CDSA, Arrest, Controlled Drugs and Substances Act, Health, Family, Friends, Child, Safety, Psychoactive Substances Act 2016, Drug

The impacts are seen and felt among our friends, our family, and our neighbours.

Key Points: 
  • The impacts are seen and felt among our friends, our family, and our neighbours.
  • Over the past years, enormous efforts and unprecedented actions have been taken by governments, healthcare professionals, harm reduction programs, researchers, and law enforcement to address this crisis.
  • As the first exemption of its kind in Canada, rigorous monitoring was put into place with the province of B.C.
  • to monitor impacts and make adjustments as needed to ensure the exemption continues to protect the health and safety of British Columbians.

Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program

Retrieved on: 
Thursday, September 7, 2023
Psilocybin, GMP, CSE, Interview, Safety, Health Canada, SAP, FRA, Quality, Controlled Substances Act, Regulation, Patient, Prohibition of drugs, Controlled Drugs and Substances Act, Special access program, MDMA, Pharmaceutical industry

The amendment empowers Optimi to embark on the formal supply journey for Canada’s Special Access Program (SAP), operating within the provisions of the Controlled Drugs and Substances Act and its Regulations.

Key Points: 
  • The amendment empowers Optimi to embark on the formal supply journey for Canada’s Special Access Program (SAP), operating within the provisions of the Controlled Drugs and Substances Act and its Regulations.
  • Under rigorous licensing regulations, Canadian entities engaged in the cultivation and formulation of psychedelic substances and who wish to supply Canada’s Special Access Program must secure approval from Health Canada's Office of Controlled Substances Division.
  • Optimi has successfully navigated this regulatory landscape, surmounting the initial hurdle required to supply MDMA and Psilocybin Drug Candidates produced under the Company’s Licence.
  • Karina Lahnakoski, Director of Quality and Commercial Strategies at Optimi, emphasizes the paramount importance of accountability in GMP supply.

Statement from the Minister of Mental Health and Addictions and Associate Minister of Health on the Overdose Crisis

Retrieved on: 
Monday, March 27, 2023
Harm reduction, CDSA, Methamphetamine, Friends, Benzodiazepine, Public, Parent, Social stigma, Controlled Substances Act, Government, Death, Cocaine, Drug, Prohibition of drugs, Controlled Drugs and Substances Act, Health, Fentanyl, MDMA, Pharmaceutical industry

Our hearts go out to all those who have lost loved ones to this crisis.

Key Points: 
  • Our hearts go out to all those who have lost loved ones to this crisis.
  • Tragically, more than 5,360 Canadians died of an overdose from January to September 2022.
  • That is nearly 20 family members, parents, children, friends and community members a day whose lives were cut short from substance use harms.
  • Together, we can save lives and end this national public health crisis.

Doseology Provides Corporate Update

Retrieved on: 
Monday, January 23, 2023
FSE, Removal of cannabis from Schedule I of the Controlled Substances Act, Head, Disclosure, CSE, Controlled Drugs and Substances Act, CPA, Bardel Entertainment, Public expenditure, Health Canada, International Forum of Independent Audit Regulators, WildBrain Studios, Acquisition, Tiki, Prohibition of drugs, Small business, Mental health, Sustainability Accounting Standards Board, Management, Financial services

In connection with the lease termination, Doseology obtained a release from the landlord of the premises from any liability arising under the lease.

Key Points: 
  • In connection with the lease termination, Doseology obtained a release from the landlord of the premises from any liability arising under the lease.
  • David Lutz, CPA has extensive experience in small business management consulting, corporate finance, and business valuation.
  • In corporate finance he helped structure, underwrite, and syndicate over $100 million in private and public stock offerings.
  • His experience includes serving as Head of Finance at Bardel Entertainment and a Senior Corporate Accountant at WildBrain Studios.

Doseology Provides Corporate Update

Retrieved on: 
Monday, January 23, 2023
FSE, Removal of cannabis from Schedule I of the Controlled Substances Act, Head, Disclosure, CSE, Controlled Drugs and Substances Act, CPA, Bardel Entertainment, Public expenditure, Health Canada, International Forum of Independent Audit Regulators, WildBrain Studios, Acquisition, Tiki, Prohibition of drugs, Small business, Mental health, Sustainability Accounting Standards Board, Management, Financial services

In connection with the lease termination, Doseology obtained a release from the landlord of the premises from any liability arising under the lease.

Key Points: 
  • In connection with the lease termination, Doseology obtained a release from the landlord of the premises from any liability arising under the lease.
  • David Lutz, CPA has extensive experience in small business management consulting, corporate finance, and business valuation.
  • In corporate finance he helped structure, underwrite, and syndicate over $100 million in private and public stock offerings.
  • His experience includes serving as Head of Finance at Bardel Entertainment and a Senior Corporate Accountant at WildBrain Studios.

Statement by Minister Lametti on Royal Assent of legislation that addresses systemic racism and discrimination in the criminal justice system

Retrieved on: 
Friday, November 18, 2022
Drug prohibition law, Adult, Correctional Service of Canada, Canadian House of Commons Standing Committee on Justice and Human Rights, House, Statistics Canada, The Honourable, Psychoactive Substances Act 2016, The Criminal Code, Legislation, Royal assent, Senate, Commons, Mental health, Criminal code, MMP, Risk, Justice, Emotion, Controlled Drugs and Substances Act, Police

These sentencing reforms will help address the overrepresentation of Indigenous people, Black persons, racialized Canadians, and members of marginalized communities in the criminal justice system.

Key Points: 
  • These sentencing reforms will help address the overrepresentation of Indigenous people, Black persons, racialized Canadians, and members of marginalized communities in the criminal justice system.
  • "Systemic racism is a reality for too many in Canada's criminal justice system.
  • These reforms will ensure a fairer, more effective justice system for all, while maintaining public safety.
  • "These evidence-based reforms address systemic racism and discrimination in our criminal justice system and keep communities safe by reducing the risk of re-offending.

Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders

Retrieved on: 
Tuesday, November 1, 2022
Rapids, SEDAR, News, CSE, DMCL, Drug prohibition law, CDSA, Ketamine, Person, Circular, Health Canada, Removal of cannabis from Schedule I of the Controlled Substances Act, Controlled Drugs and Substances Act, Company, Psilocybin, Disorder, Multimedia, Forward-looking statement, Euro-Excellence Inc v Kraft Canada Inc, Depression, Risk, Pharmaceutical industry, Audit

For more details on the matters covered at the annual meeting, please refer to the Company's management information circular available on SEDAR at www.sedar.com .Final voting results on all matters voted on at the annual meeting will also be filed on SEDAR.

Key Points: 
  • For more details on the matters covered at the annual meeting, please refer to the Company's management information circular available on SEDAR at www.sedar.com .Final voting results on all matters voted on at the annual meeting will also be filed on SEDAR.
  • Braxia Scientific is a medical research company with clinics that provide innovative ketamine treatments for persons with depression and related disorders.
  • Through its medical solutions, Braxia aims to reduce the illness burden of brain-based mental disorders such as major depressive disorder among others.
  • Braxia seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform.

KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers

Retrieved on: 
Tuesday, October 4, 2022
Post-traumatic stress disorder, OTC, National Alliance on Mental Illness, Anxiety, News, Tropical Storm Ian, Telehealth, Lists of diseases, Euro-Excellence Inc v Kraft Canada Inc, National Alliance, Psychiatry, National Helping Families in Mental Health Crisis Day, National Suicide Prevention Week, Psilocybin, CEO, Ketamine, Population, CSE, Multimedia, Disorder, COVID-19, Mental disorder, Risk, Awareness, Growth, CDSA, The Journal of Clinical Psychiatry, Clifford Whittingham Beers, Rapids, Quality of life, Controlled Drugs and Substances Act, Journal, Suicidal ideation, Patient, Person, Drug prohibition law, Diagnosis, Removal of cannabis from Schedule I of the Controlled Substances Act, Forward-looking statement, Intention, Mental health, Depression, Company, Mental Illness Awareness Week, Pharmaceutical industry, Medicine, Audit

KetaMD is committed to battling the growing mental health crisis and alleviating the growing shortage of mental health care providers in Florida and across America, both issues further exacerbated by the COVID-19 pandemic.

Key Points: 
  • KetaMD is committed to battling the growing mental health crisis and alleviating the growing shortage of mental health care providers in Florida and across America, both issues further exacerbated by the COVID-19 pandemic.
  • Mental Health Crisis by the Numbers:
    1 in 5 U.S. adults experience mental illness each year.
  • Over 6.3 million people in Florida live in a community that does not have enough mental health professionals.
  • Florida ranks 49th in the nation for access to mental health care, according to Mental Health America.

Village Farms International Recognized for Canadian Cannabis Business

Retrieved on: 
Monday, September 26, 2022
Safety, Efficiency, Delta 3 greenhouse, Rose, EBITDA, Compliance, Business, Drug prohibition law, Securities Act of 1933, The Globe and Mail, NASDAQ, Tax, Budget, Controlled Drugs and Substances Act, COVID-19, Food, Company, Acquisition, Growth, Public expenditure, Controlled Environments Magazine, Transport, Press release, United States Department of Agriculture, Food and Drug Administration, Securities Exchange Act of 1934, Netherlands, Forward-looking statement, CEO, Criminal code, Conference, Globe, Removal of cannabis from Schedule I of the Controlled Substances Act, Health, Cannabinoid, Fast-moving consumer goods, LLC, The Criminal Code, Cannabis, Private Securities Litigation Reform Act, Drug, CBD, BC

Village Farms Named Best Canadian Cannabis Company at 15th Benzinga Cannabis Capital Conference; CEO Michael DeGiglio Featured as Keynote

Key Points: 
  • Village Farms Named Best Canadian Cannabis Company at 15th Benzinga Cannabis Capital Conference; CEO Michael DeGiglio Featured as Keynote
    VANCOUVER, BC, Sept. 26, 2022 /PRNewswire/ - Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ: VFF) today announced its wholly owned subsidiary, Pure Sunfarms, ranked as the 17th fastest growing company by the Globe and Mail's Report on Business, which named Canada's Top Growing Companies across all industry sectors.
  • "Each recognition of the performance of our Canadian Cannabis business further highlights the strength and success of the Village Farms model and strategy in the cannabis industry," said Michael DeGiglio, Chief Executive Officer, Village Farms.
  • Village Farms was named Best Canadian Cannabis Company at the first Benzinga Cannabis Awards, which were presented at the 15th Benzinga Cannabis Capital Conference on September 13 and 14, 2022 in Chicago.
  • "I am so proud and honoured to accept this award on behalf of the entire Village Farms Canadian cannabis team," said Mr. DeGiglio.